Ronald M. Loeb Center for Alzheimer’s Disease

Search results

• Findings from Icahn School of Medicine at Mount Sinai Reveals New Findings on Alzheimer Disease (Progressive Excitability Changes In the Medial Entorhinal Cortex In the 3xtg Mouse Model of Alzheimer's Disease Pathology)

  Christenson Wick, Z., Philipsberg, P., Soler, I., Cai, D. & Shuman,, T.

  1/03/24

  1 item of Media coverage

  Press/Media

• -Sinaptica Completes Scientific Advisory Board with Final Expert Appointment as Company Advances to Pivotal Trial in Alzheimer's

  Pereira, A.

  29/02/24

  2 items of Media coverage

  Press/Media

• Sinaptica Therapeutics Appoints Giovanni Frisoni to Scientific Advisory Board

  Pereira, A.

  28/02/24

  1 item of Media coverage

  Press/Media

• Sinaptica Completes Scientific Advisory Board with Final Expert Appointment as Company Advances to Pivotal Trial in Alzheimer’s

  Pereira, A.

  28/02/24

  6 items of Media coverage

  Press/Media

• Investigators from Icahn School of Medicine at Mount Sinai Report New Data on Autism (Brief Report: Assessment of a Caregiver-implemented Intervention for Improving Social Communication Skills In Toddlers and Young Children With Autism)

  Foss-Feig, J. H., Kolevzon, A. & Buxbaum, J.

  28/02/24

  1 item of Media coverage

  Press/Media

• Findings on Genomics and Genetics Reported by Investigators at Icahn School of Medicine at Mount Sinai (Brain and Blood Transcriptome Profiles Delineate Common Genetic Pathways Across Suicidal Ideation and Suicide)

  Ge, Y. & Haghighi, F.

  27/02/24

  1 item of Media coverage

  Press/Media

• Scientists Discover New Telltale Sign of Alzheimer’s

  Hof, P.

  13/02/24

  1 item of Media coverage

  Press/Media

• First U.S.-Israel Alzheimer's Disease Conference will be Presented by Hebrew University

  Sano, M.

  8/02/24

  1 item of Media coverage

  Press/Media

• Reports Outline Schizophrenia Findings from Icahn School of Medicine at Mount Sinai (Convergence of the Dysregulated Regulome In Schizophrenia With Polygenic Risk and Evolutionarily Constrained Enhancers)

  Voloudakis, G., Roussos, P., Fullard, J. & Hoffman, G.

  7/02/24

  1 item of Media coverage

  Press/Media

• First US-Israel Alzheimer's Disease Conference will be presented by Hebrew University, Tel Aviv, and Rutgers University neuroscience researchers

  Sano, M.

  6/02/24

  1 item of Media coverage

  Press/Media

• First US-Israel Alzheimer’s Conference Presented by Hebrew University, Tel Aviv Univresity, and Rutgers Researchers

  Sano, M.

  6/02/24

  2 items of Media coverage

  Press/Media

• Researchers from Icahn School of Medicine at Mount Sinai Report Details of New Studies and Findings in the Area of Genetic Risk (Activity-dependent Transcriptional Program In Ngn21 Neurons Enriched for Genetic Risk for Brain-related Disorders)

  Ma, Y., Brennand, K., Roussos, P., Fullard, J. & Hoffman, G.

  6/02/24

  1 item of Media coverage

  Press/Media

• Portland man takes part in drug trial giving new hope in fight against Alzheimer’s disease

  Gandy, S.

  22/01/24

  1 item of Media coverage

  Press/Media

• Portland man takes part in Alzheimer’s drug trial

  Gandy, S.

  22/01/24

  1 item of Media coverage

  Press/Media

• Portland man takes part in drug trial giving new hope in fight against Alzheimer's disease Ralph Carmona participated in a clinical research trial for Leqembi, a new Alzheimer's drug that he believes stopped his symptoms from progressing.

  Gandy, S.

  22/01/24

  1 item of Media coverage

  Press/Media

• Portland man takes part in drug trial giving new hope in fight against Alzheimer’s disease

  Gandy, S.

  22/01/24

  3 items of Media coverage

  Press/Media

• Lower RIT2 gene activity implicated in Parkinson’s development

  Yue, Z.

  19/01/24

  1 item of Media coverage

  Press/Media

• Research cores make science easier, more fruitful, and more efficient

  Brennand, K.

  16/01/24

  1 item of Media coverage

  Press/Media

• New Findings on Gene Therapy Described by Investigators at Icahn School of Medicine at Mount Sinai (Only Hit the Bad Guys: a Gene Therapy Approach To Selectively Silence Highly Active Neurons Reduces Chronic Seizures In Epileptic Mice)

  Shuman,, T.

  15/01/24

  1 item of Media coverage

  Press/Media

• New Progressive Supranuclear Palsy Study Findings Recently Were Reported by a Researcher at Icahn School of Medicine at Mount Sinai (Investigating mechanisms of sporadic progressive supranuclear palsy in autopsy-validated human iPSC-derived ...)

  Frucht, S., Song, W.-M. & Pereira, A.

  10/01/24

  1 item of Media coverage

  Press/Media

• Reports on Science Findings from University of Wisconsin Madison Provide New Insights (The hydrogen-bonding dynamics of water to a nitrile-functionalized electrode is modulated by voltage according to ultrafast 2D IR spectroscopy)

  Yang, N.

  9/01/24

  1 item of Media coverage

  Press/Media

• Research Study Findings from Rush University Medical Center Update Understanding of Genetics (Unraveling the transcriptomic landscape of healthy aging)

  Roussos, P.

  4/01/24

  1 item of Media coverage

  Press/Media

• Nutrient found in high-protein foods helps slow aging in animals — and maybe humans, too

  Mobbs, C.

  3/01/24

  1 item of Media coverage

  Press/Media

• Findings on Cerebral Amyloid Angiopathy Discussed by Investigators at Icahn School of Medicine at Mount Sinai (Reconstruction of the Blood-brain Barrier In Vitro To Model and Therapeutically Target Neurological Disea

  Goldman, C. & Blanchard, J.

  3/01/24

  1 item of Media coverage

  Press/Media

• Research from Johns Hopkins University Medical Center Provide New Insights into Lewy Body Disease (Association of cardiovascular disease management drugs with Lewy body dementia: a case-control study)

  Goate, A.

  2/01/24

  1 item of Media coverage

  Press/Media